MY157650A - Extract from oil palm leaves comprising phenolic acids - Google Patents

Extract from oil palm leaves comprising phenolic acids

Info

Publication number
MY157650A
MY157650A MYPI20080538A MYPI20080538A MY157650A MY 157650 A MY157650 A MY 157650A MY PI20080538 A MYPI20080538 A MY PI20080538A MY PI20080538 A MYPI20080538 A MY PI20080538A MY 157650 A MY157650 A MY 157650A
Authority
MY
Malaysia
Prior art keywords
extract
oil palm
phenolic acids
palm leaves
acid
Prior art date
Application number
MYPI20080538A
Inventor
Phang Nyie Lin
Mohd Fairuz Yasmin B Abdul Khalid
Lim Chai Kuan
Siti Asmah Bt Hambali
Sharharfiza Bt Shariff
Sangeetha D O Thuraisingam
Original Assignee
Nova Lab Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nova Lab Sdn Bhd filed Critical Nova Lab Sdn Bhd
Priority to MYPI20080538A priority Critical patent/MY157650A/en
Priority to EP09718003A priority patent/EP2262518A4/en
Priority to AU2009220290A priority patent/AU2009220290A1/en
Priority to CN2009801160170A priority patent/CN102123720B/en
Priority to PCT/MY2009/000028 priority patent/WO2009110782A1/en
Priority to KR1020107022382A priority patent/KR20100136978A/en
Priority to JP2010549595A priority patent/JP2011514347A/en
Priority to TW098105514A priority patent/TW200940081A/en
Publication of MY157650A publication Critical patent/MY157650A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Medical Informatics (AREA)

Abstract

A COMPOSITION COMPRISING AN EXTRACT FROM OIL PALM LEAVES CHARACTERIZED IN THAT THE EXTRACT COMPRISES (-)-CATECHIN GALLATE, FERULIC ACID, AND PHENOLIC ACIDS SUCH AS GALLIC ACID AND PROTOCATECHUIC ACID AND A METHOD FOR PRODUCING SAID EXTRACT COMPRISING THE STEPS OF: A) EXTRACTING THE DRIED OR FRESH OIL PALM LEAVES WITH A SOLVENT, B) FILTERING THE EXTRACT OBTAINED IN (A); C) CONTACTING THE FILTERED EXTRACT FROM (B) WITH A CHROMATOGRAPHIC MEDIUM WHICH SELECTIVELY ABSORBS A FRACTION CONTAINING (-)-CATECHIN GALLATE, FERULIC ACID, AND PHENOLIC ACIDS, D) ELUTING THE SAID FRACTION FROM THE CHROMATOGRAPHIC MEDIUM USING A SOLVENT, E) DRYING THE ELUTED FRACTION OBTAINED IN STEP (D). ALSO CLAIMED IS THE USE OF THE COMPOSITION FOR REDUCING OR PREVENTING OXIDATIVE STRESS IN MAMMALS AND POULTRY.
MYPI20080538A 2008-03-06 2008-03-06 Extract from oil palm leaves comprising phenolic acids MY157650A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
MYPI20080538A MY157650A (en) 2008-03-06 2008-03-06 Extract from oil palm leaves comprising phenolic acids
EP09718003A EP2262518A4 (en) 2008-03-06 2009-02-12 Extract from oil palm leaves comprising phenolic acids
AU2009220290A AU2009220290A1 (en) 2008-03-06 2009-02-12 Extract from oil palm leaves comprising phenolic acids
CN2009801160170A CN102123720B (en) 2008-03-06 2009-02-12 Extract from oil palm leaves comprising phenolic acids
PCT/MY2009/000028 WO2009110782A1 (en) 2008-03-06 2009-02-12 Extract from oil palm leaves comprising phenolic acids
KR1020107022382A KR20100136978A (en) 2008-03-06 2009-02-12 Extract from oil palm leaves comprising phenolic acids
JP2010549595A JP2011514347A (en) 2008-03-06 2009-02-12 Extracts from oil palm leaves containing phenolic acid
TW098105514A TW200940081A (en) 2008-03-06 2009-02-20 A plant composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20080538A MY157650A (en) 2008-03-06 2008-03-06 Extract from oil palm leaves comprising phenolic acids

Publications (1)

Publication Number Publication Date
MY157650A true MY157650A (en) 2016-07-15

Family

ID=41056226

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20080538A MY157650A (en) 2008-03-06 2008-03-06 Extract from oil palm leaves comprising phenolic acids

Country Status (8)

Country Link
EP (1) EP2262518A4 (en)
JP (1) JP2011514347A (en)
KR (1) KR20100136978A (en)
CN (1) CN102123720B (en)
AU (1) AU2009220290A1 (en)
MY (1) MY157650A (en)
TW (1) TW200940081A (en)
WO (1) WO2009110782A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010039024A1 (en) * 2008-09-30 2010-04-08 Universiti Putra Malaysia A composition for wound healing
MY161839A (en) 2009-05-18 2017-05-15 Malaysian Palm Oil Board A composition for use in the prevention and treatment of cardiovascular diseases
MY185582A (en) * 2010-01-07 2021-05-24 Malaysian Palm Oil Board Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease
CN102504706B (en) * 2011-11-21 2013-07-10 陈永刚 Rare earth paint surface care solution
TWI591335B (en) 2011-12-29 2017-07-11 陶氏農業科學公司 Colorimetric determination of the total oil content of a plant tissue sample using alkaline saponification
US11064717B2 (en) 2013-02-20 2021-07-20 Palm Silage, Inc. Palm-based animal feed
US11071313B2 (en) 2013-02-20 2021-07-27 Palm Silage, Inc. Palm-based animal feed
MY179462A (en) * 2013-10-11 2020-11-06 Malaysian Palm Oil Board Protective effects of oil palm composition on alzheimer?s disease
CN103642850A (en) * 2013-12-10 2014-03-19 江南大学 Determination method of ferulic acid antioxidant activity in vitro
US20160278416A1 (en) * 2015-03-24 2016-09-29 Malaysian Palm Oil Board (Mpob) Methods for producing water soluble oil palm leaf powder and concentrate
CN111526735A (en) * 2017-12-27 2020-08-11 三得利控股株式会社 Composition for improving intestinal barrier function

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58144382A (en) * 1982-02-19 1983-08-27 Agency Of Ind Science & Technol Separation of tocopherol and tocotrienol
JPS62108876A (en) * 1985-11-07 1987-05-20 Mitsubishi Gas Chem Co Inc Production of vitamin e
JPS6363754A (en) * 1986-09-03 1988-03-22 Daiichi Eng Kk Method of separating carotene
JP2703241B2 (en) * 1987-12-29 1998-01-26 株式会社伊藤園 Method for producing crude catechin compound
JPH02219890A (en) * 1989-02-22 1990-09-03 Japan Tobacco Inc Anti-oxidizing agent
JP2004203848A (en) * 2002-12-20 2004-07-22 Lion Corp Composition containing vegetable extract
WO2007129136A1 (en) * 2006-05-08 2007-11-15 Achidi Valentin Agon Antimalarial properties of extracts of elaeis guineensis (oil palm) leaves
MY164863A (en) * 2007-07-11 2018-01-30 Univ Putra Malaysia Extract from palm leaves and a method for producing the same

Also Published As

Publication number Publication date
JP2011514347A (en) 2011-05-06
TW200940081A (en) 2009-10-01
EP2262518A1 (en) 2010-12-22
KR20100136978A (en) 2010-12-29
CN102123720A (en) 2011-07-13
WO2009110782A1 (en) 2009-09-11
EP2262518A4 (en) 2012-03-28
AU2009220290A1 (en) 2009-09-11
CN102123720B (en) 2013-11-06

Similar Documents

Publication Publication Date Title
MY157650A (en) Extract from oil palm leaves comprising phenolic acids
WO2010063975A8 (en) Zeolite adsorbent having an organic binder
BRPI0709015B8 (en) braking process between the brakes of an aircraft
WO2012078546A3 (en) Compositions and methods for stabilizing ingredients using 2,4-pentanedione compounds
Xavier et al. Aqueous two‐phase systems for the extraction of phenolic compounds from eucalyptus (Eucalyptus globulus) wood industrial wastes
EP2636734A3 (en) Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials
BR112014026806A2 (en) compound products made with lewis acid catalyzed binder compositions including multifunctional tannins and aldehydes
WO2008059358A3 (en) Structurally modified lignite with or without extraction of functionally enhanced organic molecules
ATE461988T1 (en) METHOD FOR EXTRACTING OIL FROM OIL-CONTAINING VEGETABLE SUBSTANCES
WO2009025532A3 (en) Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
Karvela et al. Factorial design optimisation of grape (Vitis vinifera) seed polyphenol extraction
MY156585A (en) Solvent composition based on an oxide of an organic sulfide with masked odor
EP2305783A4 (en) Edible olive pomace oil concentrated in triterpenic acids, procedure of physical refining utilised for obtainment thereof and recovery of functional components present in the crude oil
Jerković et al. Antioxidant capacity and chemical profiles of Satureja montana L. honey: hotrienol and syringyl derivatives as biomarkers
WO2012075275A3 (en) Novel topical composition of sarracenia purpurea (pitcher plant)
BR112012005852A2 (en) antioxidant composition, foodstuff, process for preventing and / or inhibiting oxidation of a foodstuff, use and kit for preparing a composition
임순호 et al. Structure-guided identification of novel phenolic and phenolic amide allosides from the rhizomes of Cimicifuga heracleifolia
BRPI0821025A2 (en) METHOD FOR TREATING BIOMASS, METHOD FOR PRODUCING BIOTANOL, USE OF COMPOSITION AND PROCESSED BIOMASS.
JP2016500739A5 (en)
WO2009132201A3 (en) Improved strains of zymomonas mobilis for fermentation of biomass
Ye et al. Isolation, characterization of bamboo leaf flavonoids by size exclusion chromatography and their antioxidant properties
WO2014058615A3 (en) Apparatus and method for analyte extraction
WO2010151139A3 (en) Method for isolation and quantification of naphthenate forming acids ("arn acids") in crude oil
Jabbar et al. Exploration of antioxidant activities of potentially bioactive compounds in Trianthema portulacastrum herb: chemical identification and quantification by GC‐MS and HPLC
DE602006002733D1 (en) IMPROVED METHOD FOR THE PRODUCTION OF LOW-GINK EXTRACTS ON POLYCYCLIC AROMATIC HYDROCARBONS